Department of Dermatology and Venereology, Government Medical College, Kottayam, Kerala, India.
Indian J Dermatol Venereol Leprol. 2013 Jul-Aug;79(4):506-11. doi: 10.4103/0378-6323.113080.
Toxic epidermal necrolysis (TEN) is a severe adverse drug reaction associated with high mortality. Though different modalities of treatment are advocated, there is no consensus regarding specific therapy. Corticosteroids have shown conflicting results and for high dose intravenous immunoglobulins (IVIG), cost is a limiting factor.
To find out the effectiveness of combination therapy with low-dose IVIG and steroids versus steroids alone in our TEN patients.
After obtaining Ethical Committee approval, 36 consecutive TEN patients (2008-2012) were alternately allocated to 2 groups - Group A was given combination of low-dose IVIG (0.2-0.5 g/kg) and rapidly tapering course of steroids (intravenous dexamethasone 0.1- 0.3 mg/kg/day tapered in 1-2 weeks) while Group B was given same dose of steroids alone. Outcome parameters assessed were time taken for arrest of disease progression, time taken for re-epithelization, duration of hospital stay and mortality rates.
Both groups had 18 patients. Baseline characteristics like age, sex ratio, SCORTEN, body surface area involvement and treatment interval were comparable. Time for arrest of disease progression and for re-epithelization was significantly lowered in Group A (P = 0.0001, P = 0.0009 respectively). Though duration of hospital stay and deaths were less in Group A, difference was not statistically significant. SCORTEN based standardized mortality ratio (SMR) analysis revealed that combination therapy reduced the probability of dying by 82% (SMR = 0.18 ± 0.36) and steroids by 37% (SMR = 0.63 ± 0.71). Difference in SMR was statistically significant (P = 0.00001). No significant side effects due to either modality were found in any of the patients.
Combination therapy with low-dose IVIG and steroids is more effective in terms of reduced mortality and faster disease resolution when compared to steroids alone in TEN.
中毒性表皮坏死松解症(TEN)是一种与高死亡率相关的严重药物不良反应。尽管有不同的治疗方式被提倡,但对于特定的治疗方法尚未达成共识。皮质类固醇的疗效存在争议,而大剂量静脉注射免疫球蛋白(IVIG)则受到成本的限制。
在我们的 TEN 患者中,比较低剂量 IVIG 和类固醇联合治疗与单独使用类固醇的疗效。
在获得伦理委员会批准后,将 36 例连续的 TEN 患者(2008-2012 年)交替分配到 2 组:A 组接受低剂量 IVIG(0.2-0.5g/kg)联合逐渐减量的类固醇治疗(静脉注射地塞米松 0.1-0.3mg/kg/天,在 1-2 周内逐渐减量),B 组则接受相同剂量的类固醇治疗。评估的结局参数包括疾病进展停止所需的时间、再上皮化所需的时间、住院时间和死亡率。
两组各有 18 例患者。年龄、性别比例、SCORTEN、体表面积受累和治疗间隔等基线特征相似。A 组疾病进展停止和再上皮化的时间明显缩短(P=0.0001,P=0.0009)。尽管 A 组的住院时间和死亡人数较少,但差异无统计学意义。基于 SCORTEN 的标准化死亡率(SMR)分析显示,联合治疗将死亡的概率降低了 82%(SMR=0.18±0.36),而类固醇治疗降低了 37%(SMR=0.63±0.71)。SMR 的差异具有统计学意义(P=0.00001)。两种治疗方式均未发现明显的不良反应。
与单独使用类固醇相比,低剂量 IVIG 和类固醇联合治疗在 TEN 中具有更低的死亡率和更快的疾病缓解效果。